Trial Profile
Effects of Ginkgo biloba extract (EGb 761) on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in adult healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Pharmacodynamics
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 06 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by German Clinical Trials Register record.
- 06 Jul 2012 Planned end date (23 Apr 2012) added as reported by German Clinical Trials Register record.
- 23 Apr 2012 Status changed from active, no longer recruiting to completed as reported by German Clinical Trials Register record.